000 | 01037 a2200301 4500 | ||
---|---|---|---|
005 | 20250514025636.0 | ||
264 | 0 | _c20020530 | |
008 | 200205s 0 0 eng d | ||
022 | _a1470-2045 | ||
024 | 7 |
_a10.1016/s1470-2045(00)00388-0 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCamidge, D R | |
245 | 0 | 0 |
_aBrachial plexopathy affecting the development of Beau's lines unilaterally. _h[electronic resource] |
260 |
_bThe Lancet. Oncology _cJun 2001 |
||
300 |
_a342 p. _bdigital |
||
500 | _aPublication Type: Case Reports; Journal Article | ||
650 | 0 | 4 |
_aAntineoplastic Agents, Phytogenic _xadverse effects |
650 | 0 | 4 | _aDocetaxel |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNails, Malformed _xchemically induced |
650 | 0 | 4 |
_aPaclitaxel _xadverse effects |
650 | 0 | 4 | _aTaxoids |
700 | 1 | _aCameron, D A | |
773 | 0 |
_tThe Lancet. Oncology _gvol. 2 _gno. 6 _gp. 342 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s1470-2045(00)00388-0 _zAvailable from publisher's website |
999 |
_c11811364 _d11811364 |